Search
Searching Content indexed under Patent by Cassels Brock ordered by Published Date Descending.
Links to Result pages
 
1  
 
Title
Country
Organisation
Author
Date
1
NAFTA Reintroduced As USMCA: What You Need To Know
After lengthy and intense negotiation, the North American Free Trade Agreement (NAFTA) has been reintroduced as the United States-Mexico-Canada Agreement (USMCA), the new tri-party trade...
Canada
11 Oct 2018
2
Major Changes To Canada's Intellectual Property And Patent Landscape With The Implementation Of CETA
The new CSP system provides an additional period of patent-like protection for patentees after the date of expiry of certain eligible pharmaceutical patents.
Canada
26 Sep 2017
3
SCC Rejects Promise Doctrine In Seminal Pharmaceutical Patent Case
The Supreme Court of Canada's (the "Court" or the "SCC") recent judgment in AstraZeneca Canada Inc. v Apotex Inc., released on June 30, 2017, constitutes an important paradigm shift in Canadian patent law.
Canada
13 Jul 2017
4
Major Changes Proposed To Canada's Patented Medicines Regulations
On May 16, 2017, the Federal Minister of Health, the Hon. Jane Philpott announced a number of proposed regulatory changes to the Patented Medicines Regulations (the "Regulations").
Canada
7 Jun 2017
5
Growing Pains: The Emerging Role Of IP In Selling Canadian Cannabis
Licensed producers and others looking to enter Canada's medical or recreational cannabis industry should be thinking about how they will distinguish their business, products and services...
Canada
19 May 2017
6
Eli Lilly And Company v Government Of Canada: Solidifying The Sovereignty Of Canadian Courts
Under the Patent Act in Canada, an invention must be new and useful to be patentable.
Canada
5 Apr 2017
7
Canada's Excessive Pricing Regulations Survive Another Constitutional Challenge
The Patented Medicine Prices Review Board (the "PMPRB") commenced a proceeding against Alexion Pharmaceuticals Inc...
Canada
15 Feb 2017
8
To Engage Or Not To Engage: Guidance On Motions To Strike A Within Application
The Federal Court has reaffirmed and clarified how a pharmaceutical brand company should respond to a generic company's motion to strike an application for abuse of process...
Canada
27 Jan 2017
Links to Result pages
 
1